Jewish General Hospital: Clinical Trials

148 trials sponsored by Jewish General Hospital, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

58 completed, 45 unknown, 14 recruiting, 11 terminated. 48 Not applicable, 20 Phase 2, 12 Phase 1, 11 Phase 3, 10 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable48Completed 21, Unknown 16, Terminated 4, Recruiting 3, Active not recruiting 2, Not yet recruiting 2
Phase 220Completed 9, Terminated 4, Unknown 2, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Phase 112Completed 5, Terminated 3, Active not recruiting 1, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 311Completed 7, Recruiting 2, Unknown 2
Phase 410Completed 6, Not yet recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1
Early Phase 12Not yet recruiting 1, Withdrawn 1

Follow this sponsor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
18F-FDG PET/CT for Diagnosis of Diabetic Foot Osteomyelitis
18F-FDG PET/CT - Diabetic Foot Infections
Not yet recruitingJewish General Hospital1502026-11-012026-09-18
PET/CT Imaging of GRPR Expression in Various Tumors
GRPR PET/CT - Malignancies Multiple
Early Phase 1Not yet recruitingJewish General Hospital602026-11-012026-09-18
FMT in Triple Negative Breast Cancer Guided by ctDNA
Fecal Microbiota Transplantation (FMT), No Intervention. - Breast Cancer
Phase 1 / Phase 2Not yet recruitingJewish General Hospital1252026-02-012025-12-18
Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery
Maltodextrin solution, Placebo solution - Left Ventricular Dysfunction, Quality of Recovery
Phase 4Not yet recruitingJewish General Hospital702025-12-012025-02-24
Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada
Preimplementation of HCV Point of care testing - HCV, HEPATITIS C VIRUS CHRONIC INFECTION
RecruitingMcGill University3002025-05-202025-07-31
The Impact of Fasting Duration on Quality of Recovery After Cesarean Section
Quality Improvement, Quality of Recovery From Anaesthesia
RecruitingJewish General Hospital1002025-03-182026-08-10
Best Practices Fo Early Diagnosis of Cerebral Palsy
Implementation group, Standard of care - Cerebral Palsy, Prematurity
Not applicableNot yet recruitingSt. Justine's Hospital20002025-02-012024-12-18
Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
Mycophenolate Mofetil, Placebo - Systemic Sclerosis With Lung Involvement, Systemic Sclerosis
Phase 2RecruitingCentre hospitalier de l'Université de Montréal (CHUM)352024-08-292026-09-29
Early Mobilization in Cardiovascular Units
Applying the Early Mobilization Program - Cardiovascular Diseases
Not applicableUnknownCentre for Interdisciplinary Research in Rehabilitation of Greater Montreal3502024-06-012024-05-01
CfDNA in Hereditary And High-risk Malignancies 2
Cell-free DNA analysis - Hereditary Cancer Syndrome
RecruitingUniversity Health Network, Toronto10002024-04-192026-10-08
Prophylactic EUS-guided Gastroenterostomy in Advanced Periampullary Cancers
ERCP alone, ERCP +ProEUS-GE - Cancer Gi
Not applicableRecruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre1102024-04-092024-10-01
PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL)
Psilocybin - Depression, Anxiety, Distress, Emotional
Phase 1 / Phase 2Active not recruitingOttawa Hospital Research Institute202024-01-082026-07-10
Functional Pulmonary Capillary Surface Area in BPA for CTEPH
Measurement of pulmonary functional capillary surface area - Hypertension, Pulmonary, Pulmonary Thromboembolisms
Not applicableRecruitingJewish General Hospital402023-03-232025-09-23
ER2 and Deep Learning for Prediction of Adverse Health Outcomes
ER2 - Emergencies
WithdrawnJewish General Hospital2023-02-242024-07-23
Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis
Dopamine, Norepinephrine - Late-Onset Neonatal Sepsis, Extreme Prematurity
RecruitingMount Sinai Hospital, Canada5502023-02-062026-10-16
Measuring Family Engagement in Care (The FAME Study)
Family Engagement, Patient-centered Care
RecruitingLady Davis Institute1982023-01-312025-02-13
The OPERa Study: Evaluating QoL After Rectal Cancer Surgery
Rectal Cancer, Quality of Life
Not yet recruitingJewish General Hospital12002023-01-012022-08-18
Cardiac Rehabilitation for Cardiovascular Risk Reduction in People With Severe and Persistent Mental Illness
Cardiac Rehabilitation Program - Mental Illness Persistent, Cardiovascular Prevention
Not applicableUnknownLady Davis Institute462022-12-142023-03-10
Safety and Efficacy Evaluation of Transperineal Irreversible Electroporation (IRE) of Anterior Prostate Cancer
Irreversible Electroporation (IRE) - Prostate Cancer
Not applicableUnknownJewish General Hospital102022-09-012022-08-23
Assessment of Effects of Museum Prescription of A Montreal Museum of Fine Arts Visit Tour in Primary Care Patients
The Centre of excellence self-administered (CESAM) questionnaire items - Museum, Mental Health
WithdrawnJewish General Hospital2022-07-012022-08-15

Showing 20 of 148. Sign in to see all of them.

Conditions studied

Frailty (10)  ·  Breast Neoplasms (6)  ·  Motor Activity (6)  ·  Emergencies (5)  ·  Neoplasms (5)  ·  Prostatic Neoplasms (5)  ·  Rectal Neoplasms (5)  ·  Cardiovascular Diseases (4)  ·  Depression (4)  ·  Low Anterior Resection Syndrome (4)  ·  Recurrence (4)  ·  Anxiety Disorders (3)  ·  Behavior (3)  ·  Cognitive Dysfunction (3)  ·  Head and Neck Neoplasms (3)

Interventions

Data Collection (5)  ·  Standard of Care (5)  ·  Ribavirin (4)  ·  Watchful Waiting (4)  ·  Ascorbic Acid (3)  ·  Vitamin D (3)  ·  Metformin (2)  ·  Physical Therapy Modalities (2)  ·  apixaban (2)  ·  130-nm albumin-bound paclitaxel (1)  ·  2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide (1)  ·  Adrenergic beta-Antagonists (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Arabinofuranosylcytosine Triphosphate (1)  ·  Biopsy, Large-Core Needle (1)

Countries

Canada (135)  ·  United States (10)  ·  France (3)  ·  United Kingdom (3)  ·  Germany (2)  ·  Israel (2)  ·  Italy (2)  ·  Japan (2)  ·  Norway (2)  ·  Belgium (1)  ·  Brazil (1)  ·  India (1)  ·  Ireland (1)  ·  Netherlands (1)  ·  South Africa (1)

Top investigators

Olivier Beauchet, MD (23)  ·  David Langleben, MD (3)  ·  Sarit Assouline, MD (3)  ·  Victor Cohen, MD (3)  ·  Jason Agulnik, MD (2)  ·  Jonathan Afilalo, MD, MSc (2)  ·  Katherine Borden, PhD (2)  ·  Melissa Henry, Ph.D. (2)  ·  Raymond Kim, MD (2)  ·  Simon L Bacon, PhD (2)  ·  Wilson Miller, MD, PhD (2)  ·  Ahmed Moussa, MD (1)  ·  Alan Barkun, MD (1)  ·  Alex Mlynarek, MD (1)  ·  Amish Jain, MBBS, MRCPCH, PhD (1)

Results publications

PMID 11181474, PMID 12525514, PMID 17202417, PMID 19091317, PMID 19443628, PMID 19556464, PMID 19696220, PMID 21519252, PMID 23318399, PMID 23794569, PMID 23885048, PMID 25209242, PMID 25425688, PMID 25848948, PMID 26991631, PMID 27441995, PMID 27716304, PMID 28102437, PMID 28674120, PMID 28693934, PMID 29025845, PMID 29157311, PMID 29343557, PMID 29552975, PMID 30178239, PMID 30339877, PMID 30354721, PMID 30672147, PMID 30677214, PMID 30715996, PMID 30824630, PMID 30882905, PMID 31296931, PMID 31820118, PMID 31838154, PMID 31952842, PMID 31983307, PMID 32055239, PMID 32120379, PMID 32143777, PMID 32291395, PMID 32346486, PMID 32415267, PMID 32474427, PMID 32787893, PMID 33051855, PMID 33119505, PMID 33450972, PMID 33484847, PMID 33549599